Early pulmonary arterial hypertension immediately after closure of a ventricular or complete atrioventricular septal defect beyond 6 months of age

被引:3
作者
Heck, P. Bambul [1 ]
Eicken, A. [1 ]
Kasnar-Samprec, J. [2 ]
Ewert, P. [1 ]
Hager, A. [1 ]
机构
[1] Tech Univ Munich, Dept Paediat Cardiol & Congenital Heart Dis, DHM, Lazarett Str 36, D-80290 Munich, Germany
[2] Tech Univ Munich, Dept Cardiovasc Surg, DHM, D-80290 Munich, Germany
关键词
Pulmonary arterial hypertension; VSD; CONGENITAL HEART-DISEASE; EISENMENGER-SYNDROME; SURGICAL CLOSURE; FOLLOW-UP; NITRIC-OXIDE; REPAIR; THERAPY; ADULTS;
D O I
10.1016/j.ijcard.2016.11.056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary arterial hypertension (PAH) is virtually absent after closure of ventricular septal defect (VSD) in the first six months of life. However the prevalence of PAH in patients, who underwent VSD closure later, is not clear. The aim of this study was to analyse the prevalence of PAH after a successful VSD closure after the age of 6 months and whether there are risk factors for developing PAH. Methods: Echocardiographic and right heart catheter data of patients with VSD or complete atrioventricular septal defect, who underwent VSD closure after the age of 6 months in our institution between 01/2005 and 06/2014, were retrospectively analyzed. PAH was defined as mean pulmonary arterial pressure (mPAP) of >= 25 mm Hg or tricuspid regurgitation jet velocity of >= 3.5 m/s. Results: In 228 patients (median age at shunt closure 4.0 years, range 0.5-69) and 174 complete follow-up data (median follow-up 3.7 years, range 0.5-39.4), 9 patients needed pulmonary vasodilator therapy after shunt closure, 4 of them temporarily for up to 79 months. Three patients are still on vasodilator treatment 1, 2.6 and 6 years after surgery, other two were lost to follow-up. Another 6 patients with preoperatively borderline hemo-dynamics due to elevated mPAP and pulmonary vascular resistance, recovered well without signs of postoperative PAH. Conclusion: With the current practice for safe late VSD closure, PAH is very rare at least in the first years of follow-up. In most patients with perioperative PAH, this condition appears to be transient and shows good response on pulmonary vasodilator treatment. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 30 条
[1]   Vasodilator Testing with Nitric Oxide and/or Oxygen in Pediatric Pulmonary Hypertension [J].
Barst, Robyn J. ;
Agnoletti, Gabriella ;
Fraisse, Alain ;
Baldassarre, James ;
Wessel, David L. .
PEDIATRIC CARDIOLOGY, 2010, 31 (05) :598-606
[2]  
Beghetti M., 2006, PULMONARY ARTERIAL H
[3]   Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: Factors related to nitric oxide response [J].
Cannon, BC ;
Feltes, TF ;
Fraley, JK ;
Grifka, RG ;
Riddle, EM ;
Kovalchin, JP .
PEDIATRIC CARDIOLOGY, 2005, 26 (05) :565-569
[4]   ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography) [J].
Cheitlin, MD ;
Armstrong, WF ;
Aurigemma, GP ;
Beller, GA ;
Bierman, FZ ;
Davis, JL ;
Douglas, PS ;
Faxon, DP ;
Gillam, LD ;
Kimball, TR ;
Kussmaul, WG ;
Pearlman, AS ;
Philbrick, JT ;
Rakowski, H ;
Thys, DM ;
Antman, EM ;
Smith, SC ;
Alpert, JS ;
Gregoratos, G ;
Anderson, JL ;
Hiratzka, LF ;
Faxon, DP ;
Hunt, SA ;
Fuster, V ;
Jacobs, AK ;
Gibbons, RJ ;
Russell, RO .
CIRCULATION, 2003, 108 (09) :1146-1162
[5]   Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure [J].
D'Alto, Michele ;
Romeo, Emanuele ;
Argiento, Paola ;
Correra, Anna ;
Santoro, Giuseppe ;
Gaio, Gianpiero ;
Sarubbi, Berardo ;
Calabro, Raffaele ;
Russo, Maria Giovanna .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) :3797-3801
[6]   Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy [J].
Dimopoulos, Konstantinos ;
Peset, Ana ;
Gatzoulis, Michael A. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 129 (02) :163-171
[7]   Pulmonary arterial hypertension in congenital heart disease: An epidemiologic perspective from a Dutch registry [J].
Duffels, M. G. J. ;
Engelfriet, P. M. ;
Berger, R. M. F. ;
van Loon, R. L. E. ;
Hoendermis, E. ;
Vriend, J. W. J. ;
van der Velde, E. T. ;
Bresser, P. ;
Mulder, B. J. M. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 120 (02) :198-204
[8]   Pulmonary arterial hypertension in adults born with a heart septal defect:: the Euro Heart Survey on adult congenital heart disease [J].
Engelfriet, Peter M. ;
Duffels, Marielle G. J. ;
Moller, Thomas ;
Boersma, Eric ;
Tijssen, Jan G. P. ;
Thaulow, Erik ;
Gatzoulis, Michael A. ;
Mulder, Barbara J. M. .
HEART, 2007, 93 (06) :682-687
[9]   Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood [J].
Gabriel, HM ;
Heger, M ;
Innerhofer, P ;
Zehetgruber, M ;
Mundigler, G ;
Wimmer, M ;
Maurer, G ;
Baumgartner, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (06) :1066-1071
[10]   Recall of patients discharged from follow-up after repair of isolated congenital shunt lesions [J].
Gabriels, Charlien ;
Van De Bruaene, Alexander ;
Helsen, Frederik ;
Moons, Philip ;
Van Deyk, Kristien ;
Troost, Els ;
Meyns, Bart ;
Gewillig, Marc ;
Budts, Werner .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 :314-320